证券代码：603607 证券简称：京华激光 公告编号：2025-023 浙江京华激光科技股份有限公司 第三届监事会第十四次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、监事会会议召开情况 浙江京华激光科技股份有限公司（以下简称"公司"）第三届监事会第十四 次会议于 2025 年 8 月 27 日在公司会议室以现场方式召开，会议通知已于 2025 年 8 月 15 日以书面形式发出，本次会议应出席监事 3 人，实际出席监事 3 人， 会议由监事会主席谢伟东先生主持，本次会议召开符合《公司法》等有关法律法 规和《公司章程》的规定，会议的召开合法有效。 二、监事会会议审议情况 监事会认为：公司 2025 年半年度报告全文及摘要的内容和格式符合中国证 监会和上海证券交易所的各项规定，真实准确地反映公司该报告期经营管理和财 务状况；公司 2025 年半年度报告全文及摘要的编制和审议程序符合法律法规和 《公司章程》的规定。在提出本意见前，未发现参与公司 2025 年半年度报告编 制和审核人员有违反保密规定的行为。 ...

Group 1 - The fourth temporary meeting of the fourth supervisory board of Zhejiang Chenfeng Technology Co., Ltd. was held, with all three supervisors present, and the meeting procedures complied with relevant laws and regulations [1][2] - The supervisory board approved the company's semi-annual report, confirming that its preparation and review processes met legal and internal requirements, and the report accurately reflected the company's operational and financial status [1][2] - The company decided to abolish the supervisory board, transferring its powers to the audit committee of the board of directors, and dismissed two supervisors from their positions [2] Group 2 - The resolution to abolish the supervisory board and amend the company's articles of association requires approval from the shareholders' meeting, with the proposal receiving unanimous support from the supervisors [2]

Meeting Overview - The fourth meeting of the Supervisory Board of Jilin Zhongyan High Polymer Materials Co., Ltd. was held on August 15, 2025, with all three supervisors present, complying with relevant laws and regulations [1][2]. Resolutions Passed - The Supervisory Board approved the 2025 semi-annual report, confirming that it accurately reflects the company's financial status and operations without any false statements or omissions [1][2]. - The proposal to abolish the Supervisory Board and amend the Articles of Association was approved, with the Audit Committee of the Board taking over the responsibilities of the Supervisory Board. This proposal requires approval from the shareholders' meeting [2][3]. - The proposal to abolish the "Rules of Procedure for the Supervisory Board" was approved, as the positions of shareholder representatives and employee representatives on the Supervisory Board will be eliminated [3]. - The report on the storage and actual use of raised funds for the first half of 2025 was approved, confirming compliance with relevant regulations and proper management of the funds [3][4]. - The proposal regarding the extension of certain fundraising investment projects and changes in implementation methods was approved, ensuring that these changes will not adversely affect the projects or harm shareholder interests [4][5].

中源家居股份有限公司 董事会审计委员会工作细则 (修订稿) 第一章 总则 第一条 为完善中源家居股份有限公司（以下简称"公司"）法人治理结构，促 进公司自身规范高效地运作，最大限度地规避财务和经营风险，确保各委员独立、诚 信、勤勉地履行自己的职责，根据《中华人民共和国公司法》《上市公司治理准则》 和《公司章程》及其他有关规定，公司特设立审计委员会，并制定本工作细则。 第二条 审计委员会是董事会设立的专门工作机构，对董事会负责，向董事会汇 报工作，行使《公司法》规定的监事会的职权，负责审核公司财务信息及其披露、监 督及评估内外部审计工作和内部控制。 第二章 审计委员会的产生与组成 第六条 委员连续二次未能亲自出席会议，也未能以书面形式向委员会提交对 会议议题的意见报告，视为不能履行职责，委员会应当建议董事会予以撤换。 第三章 审计委员会的职责权限 第七条 审计委员会应当行使下列职权： （五）协调管理层、内部审计部门及相关部门与外部审计机构的沟通； （六）公司董事会授权的其他事宜及相关法律法规中涉及的其他事项。 第八条 审计委员会负责审核公司财务信息及其披露、监督及评估内外部审计工 作和内部控制，下列事项应当经审 ...

中源家居股份有限公司 董事会提名委员会工作细则 (修订稿) 第一章 总则 第三条 提名委员会委员由 3 名董事组成，其中独立董事占多数。 第四条 提名委员会委员由董事长、二分之一以上独立董事或全体董事的三分之 一以上提名，并由董事会选举产生。 第五条 提名委员会设主任委员 1 名，由独立董事担任，负责召集并主持委员会 工作。主任委员在提名委员会委员内选举产生。 第六条 提名委员会任期与董事会一致，可以连选连任。期间如有委员因辞职或 其他原因不再担任公司董事职务，其委员资格自其不再担任董事之时自动丧失，由委 员会根据本工作细则的规定补足委员人数。在委员任职期间，董事会不能无故解除其 职务。 第七条 委员连续二次未能亲自出席委员会会议，也未能以书面形式向委员会提 交对会议议题的意见报告，视为不能履行职责，委员会应当建议董事会予以撤换。 第一条 为规范中源家居股份有限公司（以下简称"公司"）董事、高级管理人 员的选聘工作，优化董事会和高级管理人员的组成，完善公司治理结构，根据《中华 人民共和国公司法》《上市公司独立董事管理办法》《上市公司治理准则》和《公司章 程》及其他有关规定，公司特设立提名委员会，并制定本工作细 ...

中源家居股份有限公司 董事会薪酬与考核委员会工作细则 （修订稿） 第一章 总则 第一条 为进一步建立健全中源家居股份有限公司（以下简称"公司"）董事（非 独立董事）及高级管理人员的考核和薪酬管理制度，完善公司治理结构，根据《中华 人民共和国公司法》、《上市公司治理准则》和《公司章程》及其他有关规定，公司特 设立薪酬与考核委员会，并制定本工作细则。 第二条 薪酬与考核委员会是董事会下设的专门委员会，主要负责制定公司董事 及高级管理人员的考核标准并进行考核；负责制定、审查公司董事及高级管理人员的 薪酬政策与方案，对董事会负责。 第五条 薪酬与考核委员会委员由董事长、1/2 以上独立董事或全体董事的 1/2 以上提名，并由董事会选举产生。 第六条 薪酬与考核委员会设主任委员一名，由独立董事担任，负责召集并主持 委员会工作。主任委员在薪酬与考核委员会委员内选举产生。 第七条 薪酬与考核委员会任期与董事会一致，可以连选连任。期间如有委员因 辞职或其他原因不再担任公司董事职务，其委员资格自其不再担任董事之时自动丧 失，由委员会根据本工作细则规定补足委员人数。在委员任职期间，董事会不能无故 解除其职务。 第八条 薪酬与考核 ...

证券代码：601628 证券简称：中国人寿 编号：临 2025－026 重要提示 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 中国人寿保险股份有限公司 第八届董事会第十九次会议决议公告 本公司第八届董事会第十九次会议于 2025 年 8 月 13 日以书面方式通 知各位董事，会议于 2025 年 8 月 27 日在北京召开。会议应出席董事 12 人， 实际出席董事 11 人。执行董事利明光、刘晖、阮琦，非执行董事王军辉、 胡锦、胡容、牛凯龙，独立董事林志权现场出席会议；独立董事翟海涛、 陈洁、卢锋以视频方式出席会议。董事长、执行董事蔡希良因其他公务无 法出席会议，书面委托执行董事利明光代为出席、表决并主持会议。本公 司监事和管理层人员列席了会议。会议召开的时间、地点、方式等符合《中 华人民共和国公司法》等相关法律、行政法规、部门规章、《中国人寿保 险股份有限公司章程》（"《公司章程》"）和《中国人寿保险股份有限 公司董事会议事规则》的规定。 会议由执行董事利明光先生主持，与会董事经充分审议，一致通过如 下议案： 一、《关于 ...

Meeting Overview - The third meeting of the fourth board of directors of Tibet Weixin Kang Pharmaceutical Co., Ltd. was held on August 27, 2025, with all 7 directors present, ensuring compliance with legal and regulatory requirements [1]. Key Resolutions - The board approved the 2025 semi-annual report (full text and summary) with a unanimous vote of 7 in favor [2]. - A proposal to abolish the supervisory board and amend the company's articles of association and related rules was approved, allowing the audit committee to assume the supervisory functions [2][3]. - The board agreed to submit the proposal regarding the abolition of the supervisory board to the shareholders' meeting for approval [2][4]. - The board approved various governance system amendments, with all votes in favor [3][4]. - A proposal to convene the second extraordinary general meeting of shareholders in 2025 was approved, scheduled for September 12, 2025 [4][5].

Group 1 - The board of directors of Zhejiang Chenfeng Technology Co., Ltd. held its fifth temporary meeting in 2025, with all nine directors present, and the meeting was conducted in accordance with relevant laws and regulations [1][2]. - The board approved the proposal to cancel the supervisory board and amend certain provisions in the company's articles of association, with the supervisory board's powers to be transferred to the audit committee of the board [3][4]. - The proposal to cancel the supervisory board and amend the articles of association will be submitted to the shareholders' meeting for approval [4][5]. Group 2 - The board also approved the establishment of several new management systems, including the Independent Director Special Meeting System, Market Value Management System, and Public Opinion Management System, all aimed at enhancing corporate governance and protecting investor interests [6][7]. - The board approved the establishment of a system for managing the shareholding changes of directors and senior management, as well as a system for managing the resignation of directors and senior management [8][9]. - All proposals received unanimous support from the board, with no votes against or abstentions [2][5].

Core Points - The board of directors of Ningbo Xusheng Group Co., Ltd. held its ninth meeting of the fourth session on August 27, 2025, where all six directors were present and the meeting complied with relevant laws and regulations [1][2] Group 1: Meeting Decisions - The board approved the 2025 semi-annual report and its summary to fairly reflect the financial status and operational results for the first half of 2025, adhering to various disclosure and accounting standards [1][2] - The board approved a special report on the storage and actual use of raised funds for the first half of 2025, in compliance with legal and regulatory requirements [2] - The board approved the temporary use of up to 100 million yuan of idle raised funds to supplement working capital, ensuring that this does not affect the normal investment plans [3] - The board approved the proposal to cancel the supervisory board, change registered capital, and amend the company's articles of association and related rules, pending shareholder approval [4][5] - The board approved the evaluation report of the "Quality Improvement and Efficiency Enhancement Action Plan" for 2024 and the first half of 2025, aligning with the company's strategic goals [5] - The board proposed to convene the first extraordinary general meeting of 2025 to review related proposals that require shareholder approval [6]